Judge: Investors Failed To Link Stock Drop To Biotech Company’s Misstatements

( September 30, 2025, 2:18 PM EDT) -- SAN DIEGO — A federal judge in California granted a biotechnology company and its subsidiary’s motion to dismiss a securities fraud class action brought by investors alleging that the companies provided misleading information during the company’s acquisition of the subsidiary, finding that the investors did not establish loss causation because they did not link any of the companies’ corrective disclosures to a prior misstatement....